Literature DB >> 5052271

[Pulmonary function tests using the broncholytic agent NAB 365].

D Nolte, F Laumen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5052271

Source DB:  PubMed          Journal:  Med Monatsschr        ISSN： 0025-8474


× No keyword cloud information.
  4 in total

1.  Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients.

Authors:  Y Salorinne; B Stenius; P Tukiainen; H Poppius
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

Review 2.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

3.  Study of a new oral beta-adrenergic drug, clenbuterol, in patients with chronic bronchitis.

Authors:  A Baronti; A Griceo; C Vibelli
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

4.  The bronchodilator effect of NAB 365.

Authors:  P L Kamburoff; F J Prime; O P Schmidt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.